Tacrolimus-Induced Thrombotic Microangiopathy (TMA) Complicated by Anamnestic Donor-Specific Antibodies Post-Kidney Transplantation

被引:0
|
作者
Ibrahim, M. M. [1 ]
Manli, S. [2 ]
Kareem, S. [3 ]
Delos Santos, R. [4 ]
Alhamad, T. [4 ]
Liu, C. [2 ]
机构
[1] Univ Maryland, Dept Med, Div Nephrol, Baltimore, MD 21201 USA
[2] Washington Univ St Louis, Dept Pathol, St Louis, MO USA
[3] Univ Buffalo, Div Nephrol, Dept Med, Buffalo, NY USA
[4] Washington Univ St Louis, Div Nephrol, Dept Med, St Louis, MO USA
关键词
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
A37
引用
收藏
页码:S629 / S629
页数:1
相关论文
共 50 条
  • [21] Clinical relevance of preformed HLA donor-specific antibodies in kidney transplantation
    Lefaucheur, C.
    Suberbielle-Boissel, C.
    Andrade, J.
    Charron, D.
    Glotz, D.
    TISSUE ANTIGENS, 2008, 71 (04): : 296 - 296
  • [22] Preexisting Donor-Specific HLA Antibodies Predict Outcome in Kidney Transplantation
    Lefaucheur, Carmen
    Loupy, Alexandre
    Hill, Gary S.
    Andrade, Joao
    Nochy, Dominique
    Antoine, Corinne
    Gautreau, Chantal
    Charron, Dominique
    Glotz, Denis
    Suberbielle-Boissel, Caroline
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2010, 21 (08): : 1398 - 1406
  • [23] Donor-specific and -nonspecific HLA antibodies and outcome post lung transplantation
    Verleden, Stijn E.
    Vanaudenaerde, Bart M.
    Emonds, Marie-Paul
    Van Raemdonck, Dirk E.
    Neyrinck, Arne P.
    Verleden, Geert M.
    Vos, Robin
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50 (05)
  • [24] DONOR-SPECIFIC HLA-DQ ANTIBODIES IN KIDNEY PATIENTS WITH LIVING DONOR TRANSPLANTATION
    Ho, Eric K.
    Serban, Geo
    Ratner, Lloyd E.
    Li, Lingzhi
    Fan, Jianshe
    Vlad, George
    Vasilescu, E. Rodica R.
    HUMAN IMMUNOLOGY, 2019, 80 : 148 - 148
  • [25] De novo tacrolimus-induced thrombotic microangiopathy in the early stage after renal transplantation successfully treated with conversion to everolimus
    Cortina, Gerard
    Trojer, Raphaela
    Waldegger, Siegfried
    Schneeberger, Stefan
    Gut, Nadezda
    Hofer, Johannes
    PEDIATRIC NEPHROLOGY, 2015, 30 (04) : 693 - 697
  • [26] De novo tacrolimus-induced thrombotic microangiopathy in the early stage after renal transplantation successfully treated with conversion to everolimus
    Gerard Cortina
    Raphaela Trojer
    Siegfried Waldegger
    Stefan Schneeberger
    Nadezda Gut
    Johannes Hofer
    Pediatric Nephrology, 2015, 30 : 693 - 697
  • [27] Efficacy of plasmapheresis on donor-specific antibody reduction by HLA specificity in post-kidney transplant recipients
    Yamada, Chisa
    Ramon, Daniel S.
    Cascalho, Marilia
    Sung, Randall S.
    Leichtman, Alan B.
    Samaniego, Milagros
    Davenport, Robertson D.
    TRANSFUSION, 2015, 55 (04) : 727 - 735
  • [28] Incidence of De Novo Donor-Specific Antibodies Following Kidney Transplantation.
    Ho, B.
    Bhagat, H.
    Lee, E.
    Atiemo, K.
    Daud, A.
    Kang, R.
    Montag, S.
    Zhao, L.
    Schwartz, J.
    Ladner, D.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 : 224 - 225
  • [29] Donor-Specific HLA Antibodies: Risk Factors and Outcomes After Kidney Transplantation
    Kanter Berga, J.
    Pallardo Mateu, L. M.
    Beltran Catalan, S.
    Puig Alcaraz, N.
    Sancho Calabuig, A.
    Gavela Martinez, E.
    Avila Bemabeu, A.
    Crespo Albiach, J.
    TRANSPLANTATION PROCEEDINGS, 2011, 43 (06) : 2154 - 2156
  • [30] Living Donor Kidney Transplantation in Patients With Donor-Specific HLA Antibodies After Desensitization With Immunoadsorption
    Kaelble, Florian
    Suesal, Caner
    da Silva, Luiza Pego
    Speer, Claudius
    Benning, Louise
    Nusshag, Christian
    Pham, Lien
    Tran, Hien
    Schaier, Matthias
    Sommerer, Claudia
    Beimler, Joerg
    Mehrabi, Arianeb
    Zeier, Martin
    Morath, Christian
    FRONTIERS IN MEDICINE, 2021, 8